TILT’s founder and CEO, Akseli Hemminki is a biotech entrepreneur and cancer clinician who has personally treated almost 300 patients with ten different oncolytic viruses. Akseli leads a team of experienced industry professionals who collectively have decades of experience in the research, development, and commercialization of cancer therapeutics
